Always consult a healthcare provider if you are pregnant, breastfeeding, or have underlying medical conditions
Known side effects (class effects similar to other GLP-1 medications) Gastrointestinal issues (very common): Nausea: 38-43% of participants vs 11% placebo Diarrhea: 33-35% vs 13% placebo Vomiting: 20-21% vs 0% placebo Constipation: 22-25% vs 9% placebo Decreased appetite: 18-19% vs 9% placebo These are expected with incretin-based therapies and typically improve over time as your body adjusts
Because it is a naturally occurring compound involved in energy metabolism, adverse effects are rare
More recent systematic reviews and meta-analyses published between 2020 and 2022 have broadly confirmed this picture, reporting small, short-term reductions in body weight and body mass index, particularly in older adults and individuals with obesity or metabolic conditions, but with effect sizes that remain clinically modest
What type of medical monitoring is recommended
The cost of Ozempic varies according to insurance coverage, dosage, and drugstore pricing